Doctrine

publishing company

Doctrine specializes in the publication of peer-reviewed articles that highlights important discoveries in all aspects of microbiology. The special attention is paid to the nature of new microorganisms and their pathogenesis, genetic diversity and evolution, infectious diseases, as well as to the development and evaluation of vaccines and new antiviral or antimicrobial agents.

The objective of Doctrine is to combine the new publishing technologies with highest editorial standards declared by International Committee of Medical Journal Editors (ICMJE). More information can be found here: www.icmje.org

Key Management Staff includes specialists from Russia, Austria and USA.

Publishing policy

Doctrine is a publishing company that specializes in academic publishing. The main project of the company – the electronic scientific journal Microbiology Independent Research Journal (MIR Journal)
read more at www.mir-journal.org

MIR Journal

The Microbiology Independent Research journal (MIR journal) is a new, international resource for academic researchers and professionals in the pharmaceutical and biopharmaceutical industry. The journal publishes strictly peer-reviewed papers that cover novel aspects in virology, bacteriology, mycology as well as antimicrobial and antiviral drug discovery.

The main goal of the MIR journal is to disseminate the latest research results throughout the scientific community in order to help doctors fight bacterial and viral diseases and to improve human health worldwide. All articles are published in English.

Contacts

CEO

Romanova Sofia
finance@mir-journal.org

Publishers address

Sommerhaidenweg 100B
Vienna
1190
Austria